Page last updated: 2024-10-31

midodrine and Reperfusion Injury

midodrine has been researched along with Reperfusion Injury in 1 studies

Midodrine: An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.
midodrine : An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.

Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sun, D1
Vingrys, AJ1
Kalloniatis, M1

Other Studies

1 other study available for midodrine and Reperfusion Injury

ArticleYear
Metabolic and functional profiling of the ischemic/reperfused rat retina.
    The Journal of comparative neurology, 2007, Nov-01, Volume: 505, Issue:1

    Topics: Animals; Midodrine; Neuroglia; Neurons; Neurotransmitter Agents; Rats; Rats, Sprague-Dawley; Reperfu

2007